There has been an additional delay to the draft guidance consultation for the Early Value Assessment: Artificial intelligence (AI) technologies for assessing skin lesions referred on the urgent suspected cancer pathway being circulated. Please accept our apologies, the website will be updated with any new consultation dates in due course.

This page was last updated: